The Ritedose Corporation

2 FDA enforcement actions

2 Total Recalls

0 Class I

1 Class II

1 Class III

Firm Details

Product Types: drug
States: SC

All Recalls

Class II: Risk 07/21/2023 drug

CGMP deviation: product released prior to supplier approval.
Class III: Low Risk 04/01/2022 drug

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.